Orchid Chemicals shines on plan to enter out-licensing arrangements with MNCs

20 Sep 2012 Evaluate

Orchid Chemicals is currently trading at Rs. 114.75, up by 0.30 points or 0.26% from its previous closing of Rs. 114.45 on the BSE.

The scrip opened at Rs. 113.10 and has touched a high and low of Rs. 116.10 and Rs. 110.60 respectively. So far 1, 56,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 205.00 on 21-Sep-2011 and a 52 week low of Rs. 100.55 on 16-Aug-2012.

Last one week high and low of the scrip stood at Rs. 119.30 and Rs. 110.00 respectively. The current market cap of the company is Rs. 808 crore.

The promoters holding in the company stood at 32.42% while Institutions and Non-Institutions held 16.91% and 46.09% respectively.

Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Pharma), which is engaged in drug discovery in therapeutic segments, is planning to enter into out-licensing arrangements with multinational pharma companies (MNCs), after the successful completion of trials.

The company is in the process of transitioning its new chemical entities through various stages of pre-clinical and human clinical studies. These segments include diabetes, inflammation, cancer, auto immune disorders, anti infectives and obesity

Orchid Pharma Share Price

837.00 -6.50 (-0.77%)
09-Dec-2025 12:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1259.20
Cipla 1499.40
Zydus Lifesciences 920.40
Lupin 2060.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×